These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20493425)

  • 1. (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.
    Jansen I; Hendriksz TR; Han SH; Huiskes AW; van Bommel EF
    Eur J Intern Med; 2010 Jun; 21(3):216-21. PubMed ID: 20493425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.
    Pelkmans LG; Aarnoudse AJ; Hendriksz TR; van Bommel EF
    Nephrol Dial Transplant; 2012 Jul; 27(7):2819-25. PubMed ID: 22273666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of gallium-67 SPECT scintigraphy in the diagnostic and therapeutic evaluation of retroperitoneal fibrosis: a prospective study.
    van Bommel EF; Siemes C; van der Veer SJ; Han SH; Huiskes AW; Hendriksz TR
    J Intern Med; 2007 Aug; 262(2):224-34. PubMed ID: 17645590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Fernando A; Pattison J; Horsfield C; D'Cruz D; Cook G; O'Brien T
    Eur Urol; 2017 Jun; 71(6):926-933. PubMed ID: 27876167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG PET/CT in monitoring treatment of retroperitoneal fibrosis.
    Yilmaz S; Tan YZ; Ozhan M; Halac M; Asa S; Sönmezoglu K
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):338-9. PubMed ID: 23084017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET/CT and contrast-enhanced CT in a one-stop diagnostic procedure: a better strategy for management of patients suffering from retroperitoneal fibrosis?
    Guignard R; Simukoniene M; Garibotto V; Ratib O
    Clin Nucl Med; 2012 May; 37(5):453-9. PubMed ID: 22475894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent "scar" ? A study using 18F-fluorodeoxyglucose positron emission tomography.
    Vaglio A; Greco P; Versari A; Filice A; Cobelli R; Manenti L; Salvarani C; Buzio C
    Clin Exp Rheumatol; 2005; 23(2):231-4. PubMed ID: 15895895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermetabolic activity in patients with active retroperitoneal fibrosis on F-18 FDG PET: report of three cases.
    Young PM; Peterson JJ; Calamia KT
    Ann Nucl Med; 2008 Jan; 22(1):87-92. PubMed ID: 18250993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (18)F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease.
    Ruhlmann V; Poeppel TD; Brandt AS; Grüneisen J; Ruhlmann M; Theysohn JM; Forsting M; Bockisch A; Umutlu L
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1646-52. PubMed ID: 26969347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
    Qiao W; Zhao J; Wang C; Wang T; Xing Y
    Hematology; 2010 Feb; 15(1):21-7. PubMed ID: 20132658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of
    Wang Y; Guan Z; Gao D; Luo G; Li K; Zhao Y; Wang X; Zhang J; Jin J; Zhao Z; Yang C; Zhang J; Zhu J; Huang F
    Semin Arthritis Rheum; 2018 Feb; 47(4):593-600. PubMed ID: 28958769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis.
    Nakajo M; Jinnouchi S; Tanabe H; Tateno R; Nakajo M
    J Comput Assist Tomogr; 2007; 31(4):539-43. PubMed ID: 17882028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease activity and vascular involvement in retroperitoneal fibrosis: first experience with fully integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging compared to clinical and laboratory parameters.
    Thuermel K; Einspieler I; Wolfram S; Moog P; Meier R; Schwaiger M; Heemann U
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):146-154. PubMed ID: 27974103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of (18)F-FDG PET/CT in the assessment of active idiopathic retroperitoneal fibrosis.
    Moroni G; Castellani M; Balzani A; Dore R; Bonelli N; Longhi S; Martinelli I; Messa P; Gerundini P
    Eur J Nucl Med Mol Imaging; 2012 Oct; 39(10):1635-42. PubMed ID: 22801728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse.
    Morin G; Mageau A; Benali K; Bertinchamp R; Piekarski E; Raimbourg Q; Alexandra JF; Goulenok T; van Gysel D; Papo T; Sacre K
    Eur J Intern Med; 2019 Apr; 62():67-71. PubMed ID: 30711361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
    Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis.
    van Bommel EF; Pelkmans LG; van Damme H; Hendriksz TR
    Eur J Intern Med; 2013 Jul; 24(5):444-50. PubMed ID: 23246124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.